BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34092372)

  • 1. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
    Clark RA; Newton M; Qiao J; Lee S; Chung DH
    Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF4 Silencing Induces Cell Apoptosis and Improves Retinoic Acid Sensitivity in Human Neuroblastoma.
    Gu Y; Zhong K; Peng L; Ding W; Zeng X
    Neurochem Res; 2023 Jul; 48(7):2116-2128. PubMed ID: 36795185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.
    Duffy DJ; Krstic A; Halasz M; Schwarzl T; Konietzny A; Iljin K; Higgins DG; Kolch W
    Genome Med; 2017 Feb; 9(1):15. PubMed ID: 28187790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
    Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
    Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.
    Singh A; Rokes C; Gireud M; Fletcher S; Baumgartner J; Fuller G; Stewart J; Zage P; Gopalakrishnan V
    Cancer; 2011 Nov; 117(22):5189-202. PubMed ID: 21523764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma.
    Lautz TB; Naiditch JA; Clark S; Chu F; Madonna MB
    J Pediatr Surg; 2012 Jun; 47(6):1267-71. PubMed ID: 22703804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.
    Kolbinger FR; Koeneke E; Ridinger J; Heimburg T; Müller M; Bayer T; Sippl W; Jung M; Gunkel N; Miller AK; Westermann F; Witt O; Oehme I
    Arch Toxicol; 2018 Aug; 92(8):2649-2664. PubMed ID: 29947893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma.
    Qiao J; Rellinger EJ; Kim KW; Powers CM; Lee S; Correa H; Chung DH
    Oncotarget; 2019 Aug; 10(49):5028-5040. PubMed ID: 31489113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.
    Epping MT; Meijer LA; Bos JL; Bernards R
    Mol Cancer Res; 2009 Nov; 7(11):1861-70. PubMed ID: 19843631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
    Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.
    Kato Y; Salumbides BC; Wang XF; Qian DZ; Williams S; Wei Y; Sanni TB; Atadja P; Pili R
    Mol Cancer Ther; 2007 Jan; 6(1):70-81. PubMed ID: 17237267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
    Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
    Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid.
    Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
    Eur J Cancer; 1997 Oct; 33(12):2075-80. PubMed ID: 9516856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha.
    Nagai J; Yazawa T; Okudela K; Kigasawa H; Kitamura H; Osaka H
    Cancer Res; 2004 Nov; 64(21):7910-7. PubMed ID: 15520197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
    Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
    Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
    Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
    Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
    Rettig I; Koeneke E; Trippel F; Mueller WC; Burhenne J; Kopp-Schneider A; Fabian J; Schober A; Fernekorn U; von Deimling A; Deubzer HE; Milde T; Witt O; Oehme I
    Cell Death Dis; 2015 Feb; 6(2):e1657. PubMed ID: 25695609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.